Here is the latest shareholding Pattern of ASTRAZENECA PHARMA. For more details, see the ASTRAZENECA PHARMA financial fact sheet and ASTRAZENECA PHARMA share price. For a sector overview, read our pharmaceuticals sector report.
No. of Mths Qtr. Ending |
3
Mar-21 |
3
Jun-21 |
3
Sep-21 |
3
Dec-21 |
3
Mar-22 |
3
Jun-22 |
3
Sep-22 |
3
Dec-22 |
||
---|---|---|---|---|---|---|---|---|---|---|
Indian Promoters | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Foreign Promoters | % | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | |
Total Promoters | % | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | 75.00 | |
Mutual Funds | % | 0.83 | 0.94 | 0.93 | 0.97 | 0.99 | 1.07 | 1.09 | 1.22 | |
Financial institution/Banks/Insurance | % | 0.00 | 0.00 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.00 | |
Government | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
FII | % | 2.43 | 2.42 | 2.40 | 2.38 | 2.38 | 2.48 | 2.49 | 2.61 | |
Other | % | 0.10 | 0.08 | 0.09 | 0.14 | 0.17 | 0.20 | 0.20 | 0.20 | |
Total Institution | % | 3.36 | 3.44 | 3.45 | 3.52 | 3.57 | 3.78 | 3.81 | 4.03 | |
Bodies Corporate | % | 1.45 | 1.22 | 1.23 | 1.45 | 1.73 | 2.03 | 1.67 | 1.46 | |
Individuals | % | 19.53 | 19.72 | 19.70 | 19.44 | 19.06 | 18.63 | 18.54 | 18.56 | |
NRIs/OCBs | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.41 | 0.39 | |
ADR/GDR | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Others | % | 0.66 | 0.62 | 0.62 | 0.59 | 0.64 | 0.56 | 0.56 | 0.56 | |
Total Non-Institution | % | 21.64 | 21.56 | 21.55 | 21.48 | 21.43 | 21.22 | 21.18 | 20.97 | |
Total Public | % | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | 25.00 | |
Grand Total | % | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | 100.00 | |
Pledged Promoter Holding | % | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
![]() |
More Pharmaceuticals Company Shareholding Pattern: PIRAMAL ENTERPRISES ZYDUS LIFESCIENCES AUROBINDO PHARMA CIPLA LUPIN
After opening the day on a strong note, Indian share markets continued their momentum throughout the trading session and had their best day in months.